Shanghai Labway Clinical Laboratory (301060.SZ) shareholder Hailan Group plans to reduce its shareholding by no more than 2%.

12/11/2024

Lanwei Medical (301060.SZ) announced that its shareholder Hailan Group Co., Ltd. (referred to as "Hailan Group") plans to...

Announcement from Shanghai Labway Clinical Laboratory (301060.SZ): The company's shareholder, Hailan Group Limited (referred to as "Hailan Group"), plans to reduce its holdings of the company's shares by no more than 7.9704 million shares (representing 2.00% of the total share capital excluding shares held in the company's repurchase special account) through centralized bidding and/or block trading within 3 months after 15 trading days from the disclosure of this reduction plan.

Purple Gold International (02259) will be open for subscription from September 19 to September 24 and is expected to be listed on September 29th.

Westsutney (02583) will conduct stock subscription from September 19th to September 24th, and is expected to be listed on September 29th.

A-share subscription | Ruili Ke Mi (001285.SZ) opens for subscription, with the highest market share in pneumatic electric control motion system products.

Purple Gold International (02259) will be open for subscription from September 19 to September 24 and is expected to be listed on September 29th.

Westsutney (02583) will conduct stock subscription from September 19th to September 24th, and is expected to be listed on September 29th.

A-share subscription | Ruili Ke Mi (001285.SZ) opens for subscription, with the highest market share in pneumatic electric control motion system products.